Edition:
United Kingdom

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

0.17USD
26 Jun 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.17
Open
$0.16
Day's High
$0.17
Day's Low
$0.16
Volume
76,191
Avg. Vol
278,098
52-wk High
$1.29
52-wk Low
$0.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 6.84 -0.094
FY 2018 Dec '18 6.83 -0.136
Sep '18 5.94 -0.311
Jun '18 7.04 -0.134
Mar '18 7.67 -0.165
FY 2017 Dec '17 7.52 0.325
Sep '17 8.03 -0.029
Jun '17 6.60 -0.140
Mar '17 6.97 -0.507
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 23.26 37.22
P/E High - Last 5 Yrs. -- 116.34 57.50
P/E Low - Last 5 Yrs. -- 26.86 28.56
Beta 1.54 0.50 0.96
Price to Sales (TTM) 0.37 6.32 11.26
Price to Book (MRQ) 1.24 3.97 4.52
Price to Tangible Book (MRQ) -- 6.19 5.33
Price to Cash Flow (TTM) -- 15.80 25.90
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.12 1.62
Dividend Yield - 5 Year Avg -- 0.87 1.35
Dividend 5 Year Growth Rate -- 5.74 6.51
Payout Ratio(TTM) -- 24.08 39.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -10.80 10.21 15.47
Sales (TTM) vs TTM 1 Yr. Ago -10.66 7.17 8.81
Sales - 5 Yr. Growth Rate 32.96 10.95 10.36
EPS (MRQ) vs Qtr. 1 Yr. Ago 42.73 68.93 18.33
EPS (TTM) vs TTM 1 Yr. Ago -6,991.81 -- --
EPS - 5 Yr. Growth Rate -- 6.01 7.10
Capital Spending - 5 Yr. Growth Rate 14.24 2.95 7.91

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.19 2.47
Current Ratio (MRQ) 0.36 3.41 3.43
LT Debt to Equity (MRQ) 3.83 38.92 14.20
Total Debt to Equity (MRQ) 153.76 50.97 19.90
Interest Coverage (TTM) -- 30.47 15.19

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 31.39 40.95 49.98
Gross Margin - 5 Yr. Avg. 31.67 40.88 51.24
EBITD Margin (TTM) -55.34 -- --
EBITD - 5 Yr. Avg -75.95 12.67 16.31
Operating Margin (TTM) -74.88 7.57 -10.49
Operating Margin - 5 Yr. Avg. -87.51 6.80 11.55
Pre-Tax Margin (TTM) -77.07 10.50 -10.99
Pre-Tax Margin - 5 Yr. Avg. -88.93 7.80 16.30
Net Profit Margin (TTM) -77.07 7.02 -14.78
Net Profit Margin - 5 Yr. Avg. -70.32 5.15 11.48
Effective Tax Rate (TTM) -- 28.68 20.19
Effective Tax Rate - 5 Yr. Avg. -- 135.60 24.40

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 2,075,901 794,118,785
Net Income/Employee (TTM) -- -111,576 93,433,457
Receivable Turnover (TTM) 3.02 8.63 5.83
Inventory Turnover (TTM) -- 76.18 3.68
Asset Turnover (TTM) 0.63 0.69 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.35 7.19 9.76
Return on Assets - 5 Yr. Avg. -33.35 6.31 10.70
Return on Investment (TTM) -114.41 8.97 12.18
Return on Investment - 5 Yr. Avg. -45.46 7.99 13.61
Return on Equity (TTM) -148.08 -0.10 17.03
Return on Equity - 5 Yr. Avg. -53.85 11.34 15.11
  1 Year 3 Year 5 Year
Sales % -5.67 15.05 32.96
EPS (TTM) % -171.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cancer Genetics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.14 -8.88 27 45
13 Week -32.08 -34.38 11 61
26 Week -43.96 -54.84 8 28
52 Week -80.26 -81.61 5 50
YTD -29.83 -39.71 14 42
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 15.81%
# of Holders: 27
Total Shares Held: 9,143,186
3 Mo. Net Change: 6,664,559
# New Positions: 4
# Closed Positions: 8
# Increased Positions: 10
# Reduced Positions: 12
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.